Atlas Trials

Effect of SRT2104 on Endotoxin-induced Inflammation

Clinical trial NCT01014117 · COMPLETED

Trial details

NCT number
NCT01014117
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Sepsis
Start date
2009-12-09
Primary completion
2010-05-10
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.